Home » Topics » BioWorld Science

BioWorld Science
RSS

Suven Life Sciences presents preclinical data for SUVN-M-8036

Aug. 2, 2018

Karuna Pharmaceuticals announces plans to advance KarXT to phase II

Aug. 2, 2018

Azitra obtains support to further study microbiome therapeutic for Netherton syndrome

Aug. 2, 2018

NLY-001 shows neuroprotective effect by blocking A1 astrocyte conversion in Parkinson's mice models

Aug. 2, 2018

Clover Biopharmaceuticals begins phase I study of etancercept biosimilar SCB-808

Aug. 2, 2018

Phase II trial shows no clinical benefit of valproic acid in autosomal dominant retinitis pigmentosa

Aug. 2, 2018

Phase II study of Nicox's NCX-470 begins

Aug. 2, 2018

Shionogi's Mulpleta wins approval in the U.S.

Aug. 2, 2018

RXI-109 shows promising results in phase I/II study in NVAMD

Aug. 2, 2018

BioLineRx begins phase I/IIa study of cancer immunotherapy AGI-134

Aug. 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...